Cargando…
Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report
Recently published observational data suggests an increased risk of herpes zoster infection post-vaccination with the BNT162b2 mRNA vaccine. We describe the case of VZV meningitis post BNT162b2 mRNA vaccination in a young immunocompetent patient. A 39-year-old patient with no medical history present...
Autores principales: | Kerr, Colm, O’Neill, Susan, Szucs, Anna, Darmody, Oliver, Williamson, Claire, Bannan, Ciaran, Merry, Concepta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837498/ https://www.ncbi.nlm.nih.gov/pubmed/35186672 http://dx.doi.org/10.1016/j.idcr.2022.e01452 |
Ejemplares similares
-
A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient
por: Maruki, Taketomo, et al.
Publicado: (2021) -
Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
por: Medhat, R., et al.
Publicado: (2022) -
Zoster sine herpete following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient
por: Tanizaki, Ryutaro, et al.
Publicado: (2022) -
A Rare Case of an Immunocompetent Male With Zoster
Meningitis
por: Faluk, Mohammed Ali, et al.
Publicado: (2020) -
Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
por: Saito, Kazuyuki, et al.
Publicado: (2021)